Search

everythinglearnresearchcommunity

for

Search:↓

Higher DHT in male baldness may protect against prostate cancer.

Certain chemicals cause hair graying in black mice but not yellow mice.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

UV light might cause excessive hair growth by increasing PGE2 in the skin.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.

Latanoprost eye drops caused excessive hair growth and eyelash whitening in a woman.

Injected bimatoprost 0.03% solution did not effectively treat female-pattern hair loss.

Prostaglandins may protect hair follicles during chemotherapy.

Minoxidil promotes hair growth but exact mechanism is unknown.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

Testosterone may worsen hair loss by affecting hair growth signals, while different prostaglandins can either hinder or promote hair growth.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

Two children grew extra hair from taking omeprazole, which went away after they stopped the medication.

A woman got unwanted hair growth on her face from using bimatoprost eyedrops for glaucoma.

The document concludes that more research is needed on treatments for hair loss in both men and women, especially on medication combinations and their benefits.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Latanoprost eye drops caused excessive cheek hair growth and eyelash whitening in a woman.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Double stranded RNA helps skin wounds heal by coordinating specific proteins and signaling pathways.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

The enzyme sEH is important for hair growth and its inhibition could help treat hair loss.